The group’s principal activities include creating, developing and distributing proprietary formulations of natural products. The group markets its products under the trade names LarreaRx(TM) and Shegoi(TM). The group operates from the United States and Canada. Of the total revenue in the year 2006, the United States accounted for $347,196 and Canada $110,486.
